Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted delivery of cancer drug paclitaxel to chordomas tumor cells via an RNA nanoparticle harboring an EGFR aptamer
Dan Xiao, Yongxiong Huang, Shuaihao Huang, et al.
Colloids and Surfaces B Biointerfaces (2022) Vol. 212, pp. 112366-112366
Closed Access | Times Cited: 19

Showing 19 citing articles:

Membrane Internalization Mechanisms and Design Strategies of Arginine-Rich Cell-Penetrating Peptides
Minglu Hao, Lei Zhang, Pu Chen
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9038-9038
Open Access | Times Cited: 61
Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics
Afsana Sheikh, Shadab Md, Nabil A. Alhakamy, et al.
International Journal of Pharmaceutics (2022) Vol. 620, pp. 121751-121751
Closed Access | Times Cited: 51
Silk sericin-based biomaterials shine in food and pharmaceutical industries
Chao Yang, Liang Yao, Lei Zhang
Smart Materials in Medicine (2023) Vol. 4, pp. 447-459
Open Access | Times Cited: 31
Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies
Simona Camorani, Alessandra Caliendo, Elena Morrone, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 8
Peptide-modified bioresponsive chondroitin sulfate micelles for targeted doxorubicin delivery in triple-negative breast cancer
Jingmou Yu, Liangliang Wang, Yun Ling, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 227, pp. 113381-113381
Closed Access | Times Cited: 17
Advances in the polymeric nanoparticulate delivery systems for RNA therapeutics
Sristi, Waleed Hassan Almalki, Ritu Karwasra, et al.
Progress in molecular biology and translational science (2024), pp. 219-248
Closed Access | Times Cited: 4
Innovative gelatin-based micelles with AS1411 aptamer targeting and reduction responsiveness for doxorubicin delivery in tumor therapy
Jingmou Yu, Yifei Zhang, Meilin Xu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116446-116446
Open Access | Times Cited: 4
Evaluation of the effects of a dasatinib-containing, self-emulsifying, drug delivery system on HT29 and SW420 human colorectal carcinoma cells, and MCF7 human breast adenocarcinoma cells
Rehab A Baghdadi, Ashraf N. Abdalla, Mohammed A. S. Abourehab, et al.
Journal of Taibah University Medical Sciences (2024) Vol. 19, Iss. 4, pp. 806-815
Open Access | Times Cited: 4
Surface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting
Alessandra Spada, Sandrine Gerber‐Lemaire
Nanomaterials (2025) Vol. 15, Iss. 3, pp. 158-158
Open Access
An engineered M2 macrophage-derived exosomes-loaded electrospun biomimetic periosteum promotes cell recruitment, immunoregulation, and angiogenesis in bone regeneration
Zhuohao Wen, Shuyi Li, Yi Liu, et al.
Bioactive Materials (2025) Vol. 50, pp. 95-115
Closed Access
Aptamers for the Delivery of Plant-Based Compounds: A Review
Joana Gamboa, Pedro Lourenço, Carla Cruz, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 541-541
Open Access | Times Cited: 3
Hedgehog pathway and its inhibitors in chronic obstructive pulmonary disease (COPD)
Zakaria Mohamed Lahmar, Engi Ahmed, Aurélie Fort, et al.
Pharmacology & Therapeutics (2022) Vol. 240, pp. 108295-108295
Open Access | Times Cited: 14
Current and Emerging Approaches for Spine Tumor Treatment
Bogdan Costăchescu, Adelina-Gabriela Niculescu, B. Iliescu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15680-15680
Open Access | Times Cited: 14
Smart Targeted-Nanocarriers for Cancer Therapeutics
Débora Ferreira, Renata Silva, Laura Figueiredo, et al.
Environmental science and engineering (2024), pp. 377-407
Closed Access | Times Cited: 1
Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies
Simona Camorani, Alessandra Caliendo, Elena Morrone, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Recent Advances and Challenges in Targeted Drug Delivery Using Biofunctional Coatings
Tuğba Bal, Nasma Anjrini, Meryem Zeroual
Royal Society of Chemistry eBooks (2024), pp. 41-75
Closed Access
Aptamer-Based Nanoparticles for Cancer Therapy
Shahrzad Dehghani, Seyed Mohammad Taghdisi, Khalil Abnous, et al.
(2024), pp. 791-816
Closed Access
Targeted therapy, immunotherapy, and chemotherapy for chordoma
Xue Yang, Parker Li, Zhuang Kang, et al.
Current Medicine (2023) Vol. 2, Iss. 1
Open Access | Times Cited: 1
Hedgehog Pathway and its Inhibitors in Chronic Obstructive Pulmonary Disease (COPD)
Zakaria Mohamed Lahmar, Engi Ahmed, Aurélie Fort, et al.
SSRN Electronic Journal (2022)
Open Access
Page 1

Scroll to top